(Total Views: 1134)
Posted On: 08/07/2020 12:40:39 AM
Post# of 148903
CytoDyn Seeks UK Approval of Leronlimab for HIV and COVID-19
BLA-type submission planned this month in U.K. for HIV combination therapy with 350 mg weekly dose
COVID-19 Phase 2 topline report to be submitted for consideration of emergency approval of leronlimab for patients with mild-to-moderate symptoms to U.K. and other countries following submission to the U.S. FDA next week
https://www.cytodyn.com/newsroom/press-releas...d-covid-19
BLA-type submission planned this month in U.K. for HIV combination therapy with 350 mg weekly dose
COVID-19 Phase 2 topline report to be submitted for consideration of emergency approval of leronlimab for patients with mild-to-moderate symptoms to U.K. and other countries following submission to the U.S. FDA next week
https://www.cytodyn.com/newsroom/press-releas...d-covid-19
(8)
(0)Scroll down for more posts ▼
